SCI
ABBV icon

SkyBridge Capital II’s AbbVie ABBV Stock Holding History

SkyBridge Capital II’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-29,830
Closed -$2.17M – 1
2019
Q2 		$2.17M Buy
+29,830
New +$2.34M 3.1% 26
2018
Q2 		– Sell
-106,798
Closed -$10.1M – 31
2018
Q1 		$10.1M Sell
106,798
-38,540
-27% -$4.23M 4.91% 2
2017
Q4 		$14.1M Sell
145,338
-30,198
-17% -$2.85M 4.67% 3
2017
Q3 		$15.6M Sell
175,536
-37,388
-18% -$2.85M 4.54% 2
2017
Q2 		$15.4M Sell
212,924
-45,771
-18% -$3.08M 3.7% 6
2017
Q1 		$16.9M Sell
258,695
-9,855
-4% -$620K 3.67% 12
2016
Q4 		$16.8M Buy
268,550
+29,936
+13% +$1.83M 3.5% 14
2016
Q3 		$15M Buy
238,614
+22,769
+11% +$1.47M 3.42% 11
2016
Q2 		$13.4M Buy
+215,845
New +$13.2M 3.53% 9

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SkyBridge Capital II's ABBV Position: Q3 2019 in Review

SkyBridge Capital II sold out of AbbVie (ABBV) in Q3 2019, closing a stake of 29,830 shares — an estimated $2.17M sold.

SkyBridge Capital II first reported a position in ABBV in Q2 2016 and held it in 9 quarters. The position peaked at $16.9M in Q1 2017. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • SkyBridge Capital II reported no remaining AbbVie position as of Q3 2019 after selling out during the quarter.
  • SkyBridge Capital II sold 29,830 AbbVie shares in Q3 2019, an estimated $2.17M.
  • SkyBridge Capital II first reported a position in AbbVie in Q2 2016 and held it in 9 quarters.
  • SkyBridge Capital II's AbbVie position peaked at $16.9M in Q1 2017.
  • 2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on SkyBridge Capital II's 13F filing for Q3 2019.